期刊文献+

索非布韦联合利巴韦林治疗肝移植术后丙型病毒性肝炎复发:附1例报告 被引量:7

下载PDF
导出
摘要 报道1例通过自行服用索非布韦+利巴韦林成功治疗肝移植术后丙型病毒性肝炎(丙肝)复发的个案,为肝移植术后丙肝复发的治疗提供参考,以延长移植肝的存活时间,改善患者的预后。索非布韦+利巴韦林方案能快速有效地降低肝移植术后血清丙型肝炎病毒(HCV)RNA定量,消除病毒对移植肝损伤,因此可作为肝移植术后丙肝复发的有效治疗手段,但仍需密切观察白细胞减低等不良反应的发生情况。
出处 《器官移植》 CAS CSCD 2016年第1期61-63,共3页 Organ Transplantation
基金 国家自然科学基金(81470896)
  • 相关文献

参考文献2

二级参考文献11

  • 1Shepard CW,Finelli L,Alter MJ.Global epidemiology of hepatitis C virus infection[].The Lancet Infectious Diseases.2005
  • 2Chopra A,Klein PL,Drinnan T,Lee SS.How to optimize HCV therapy in genotype1patients:man-agement of side-effects[].Liver International.2013
  • 3GL Davis,JB Wong,JG McHutchison,MP Manns,J Harvey,J Albrecht.Early virologic response to treatment with peginterferon alpha-2a plus ribavirin in patients with chronic hepatitis C[].Hepatology.2003
  • 4Hoofnagle,JH,Mullen,KD,Jones,DB,Rustgi,V,Di,Bisceglie,A,Peters,M,Waggoner,JG,Park,Y,Jones,EA.Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon: A preliminary report[].The New England Journal of Medicine.1986
  • 5Marcellin,P,Boyer,N,Giostra,E,Degott,C,Courouce,AM,Degos,F,Coppere,H,Cales,P,Couzigou,P,Benhamou,J-P.Recombinant human α-interferon in patients with chronic non-A, non-B hepatitis: A multicenter randomized controlled trial from France[].Hepatology.1991
  • 6Braconier JH,Paulsen O,Engman K.Combined alpha-interferon and rlbavirin treament in chronic hepatitis C:a pilot study[].Scand j Inpect Dis.1995
  • 7Schafer D F,Sorrell M F.Conquering hepatitis C,step by step[].The New England Journal of Medicine.2000
  • 8Fried MW,Shiffman ML,Reddy KR,Smith C,Marinos G,Goncales FL, Jr,Haussinger D,Diago M,Carosi G,Dhumeaux D,Craxi A,Lin A,Hoffman J,Yu J.Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection[].The New England Journal of Medicine.2002
  • 9Swain MG,Lai MY,Shiffman ML,Cooksley WG,Zeuzem S,Dieterich DT,Abergel A,Pess a MG,Lin A,Tietz A,Connell EV,Diago M.A sustained virologic response is durable in patients with chronic hepatitis C treated with peginterferon alfa-2a and ribavirin[].Gastroenterology.2010
  • 10Ge D,Fellay J,Thompson AJ,Simon JS,Shianna KV,Urban TJ,Heinzen EL,Qiu P,Bertelsen AH,Muir AJ,Sulkowski M,McHutchison JG,Goldstein DB.Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance[].Nature.2009

共引文献121

同被引文献34

引证文献7

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部